Colinz Laboratories schedules board meeting on 29th April 2026 to approve audited financial results for Q4 and FY ended 31st March 2026.
The trading window for company securities is closed from 1st April 2026 until the second trading day after the board meeting.
This is a regulatory disclosure to BSE pursuant to SEBI LODR Regulation 29(2) requirements.